131 related articles for article (PubMed ID: 34174024)
21. Two cases of dabrafenib and trametinib therapy-failed advanced melanoma successfully controlled by nivolumab monotherapy.
Sato Y; Fujimura T; Kambayashi Y; Tanita K; Tono H; Hashimoto A; Aiba S
J Dermatol; 2018 Sep; 45(9):1105-1108. PubMed ID: 29923635
[TBL] [Abstract][Full Text] [Related]
22. Erythema Nodosum-Like Panniculitis as a False-Positive 18F-FDG PET/CT in Advanced Melanoma Treated With Dabrafenib and Trametinib.
Martínez-Rodríguez I; García-Castaño A; Quirce R; Jiménez-Bonilla J; Banzo I
Clin Nucl Med; 2017 Jan; 42(1):44-46. PubMed ID: 27775948
[TBL] [Abstract][Full Text] [Related]
23. Healthcare resource utilization in patients with metastatic melanoma receiving first-line therapy with dabrafenib + trametinib versus nivolumab or pembrolizumab monotherapy.
Ghate SR; Ionescu-Ittu R; Burne R; Ndife B; Laliberté F; Nakasato A; Duh MS
Curr Med Res Opin; 2018 Dec; 34(12):2169-2176. PubMed ID: 30009647
[TBL] [Abstract][Full Text] [Related]
24. Usefulness of translocation-associated immunohistochemical stains in the fine-needle aspiration diagnosis of salivary gland neoplasms.
Foo WC; Jo VY; Krane JF
Cancer Cytopathol; 2016 Jun; 124(6):397-405. PubMed ID: 26882287
[TBL] [Abstract][Full Text] [Related]
25. Systemic Therapy for Melanoma: ASCO Guideline.
Seth R; Messersmith H; Kaur V; Kirkwood JM; Kudchadkar R; McQuade JL; Provenzano A; Swami U; Weber J; Alluri KC; Agarwala S; Ascierto PA; Atkins MB; Davis N; Ernstoff MS; Faries MB; Gold JS; Guild S; Gyorki DE; Khushalani NI; Meyers MO; Robert C; Santinami M; Sehdev A; Sondak VK; Spurrier G; Tsai KK; van Akkooi A; Funchain P
J Clin Oncol; 2020 Nov; 38(33):3947-3970. PubMed ID: 32228358
[TBL] [Abstract][Full Text] [Related]
26. Fine-Needle Aspiration Cytology of Cellular Basaloid Neoplasms of the Salivary Gland.
Cantley RL
Arch Pathol Lab Med; 2019 Nov; 143(11):1338-1345. PubMed ID: 31509452
[TBL] [Abstract][Full Text] [Related]
27. Pitfalls of fine-needle aspiration cytology of parotid membranous basal cell adenoma-A review of pitfalls in FNA cytology of salivary gland neoplasms with basaloid cell features.
Jurczyk M; Peevey JF; Vande Haar MA; Lin X
Diagn Cytopathol; 2015 May; 43(5):432-7. PubMed ID: 25431027
[TBL] [Abstract][Full Text] [Related]
28. Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparations.
Sheffield MV; Yee H; Dorvault CC; Weilbaecher KN; Eltoum IA; Siegal GP; Fisher DE; Chhieng DC
Am J Clin Pathol; 2002 Dec; 118(6):930-6. PubMed ID: 12472287
[TBL] [Abstract][Full Text] [Related]
29. [A woman with a skin lesion suspected for melanoma].
Post NF; Huis In 't Veld E; Crijns MB
Ned Tijdschr Geneeskd; 2020 Feb; 164():. PubMed ID: 32267633
[TBL] [Abstract][Full Text] [Related]
30. Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected
Hauschild A; Dummer R; Schadendorf D; Santinami M; Atkinson V; Mandalà M; Chiarion-Sileni V; Larkin J; Nyakas M; Dutriaux C; Haydon A; Robert C; Mortier L; Schachter J; Lesimple T; Plummer R; Dasgupta K; Haas T; Shilkrut M; Gasal E; Kefford R; Kirkwood JM; Long GV
J Clin Oncol; 2018 Dec; 36(35):3441-3449. PubMed ID: 30343620
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.
Long GV; Hauschild A; Santinami M; Atkinson V; Mandalà M; Chiarion-Sileni V; Larkin J; Nyakas M; Dutriaux C; Haydon A; Robert C; Mortier L; Schachter J; Schadendorf D; Lesimple T; Plummer R; Ji R; Zhang P; Mookerjee B; Legos J; Kefford R; Dummer R; Kirkwood JM
N Engl J Med; 2017 Nov; 377(19):1813-1823. PubMed ID: 28891408
[TBL] [Abstract][Full Text] [Related]
32. Open-label, phase IIa study of dabrafenib plus trametinib in East Asian patients with advanced BRAF V600-mutant cutaneous melanoma.
Si L; Zhang X; Shin SJ; Fan Y; Lin CC; Kim TM; Dechaphunkul A; Maneechavakajorn J; Wong CS; Ilankumaran P; Lee DY; Gasal E; Li H; Guo J
Eur J Cancer; 2020 Aug; 135():31-38. PubMed ID: 32534242
[TBL] [Abstract][Full Text] [Related]
33. Comparative efficacy of combination immunotherapy and targeted therapy in the treatment of BRAF-mutant advanced melanoma: a matching-adjusted indirect comparison.
Atkins MB; Tarhini A; Rael M; Gupte-Singh K; O'Brien E; Ritchings C; Rao S; McDermott DF
Immunotherapy; 2019 May; 11(7):617-629. PubMed ID: 30852924
[TBL] [Abstract][Full Text] [Related]
34. Comparative efficacy and safety of adjuvant nivolumab versus other treatments in adults with resected melanoma: a systematic literature review and network meta-analysis.
Toor K; Middleton MR; Chan K; Amadi A; Moshyk A; Kotapati S
BMC Cancer; 2021 Jan; 21(1):3. PubMed ID: 33402121
[TBL] [Abstract][Full Text] [Related]
35. Fine-needle aspiration biopsy of large-cell undifferentiated carcinoma of the salivary glands: presentation of two cases, literature review, and differential cytodiagnosis of high-grade salivary gland malignancies.
Moore JG; Bocklage T
Diagn Cytopathol; 1998 Jul; 19(1):44-50. PubMed ID: 9664183
[TBL] [Abstract][Full Text] [Related]
36. Clinical and radiological response of BRAF inhibition and MEK inhibition in patients with brain metastases from BRAF-mutated melanoma.
Geukes Foppen MH; Boogerd W; Blank CU; van Thienen JV; Haanen JB; Brandsma D
Melanoma Res; 2018 Apr; 28(2):126-133. PubMed ID: 29356790
[TBL] [Abstract][Full Text] [Related]
37. Uveitis and Papillitis in the Setting of Dabrafenib and Trametinib Therapy for Metastatic Melanoma: A Case Report.
Lim J; Lomax AJ; McNeil C; Harrisberg B
Ocul Immunol Inflamm; 2018; 26(4):628-631. PubMed ID: 27892777
[TBL] [Abstract][Full Text] [Related]
38. Tattoo-associated complications of metastatic melanoma treated with dabrafenib and trametinib.
Laske J; Meier F; Bauer A; Beissert S; Garzarolli M
Melanoma Res; 2018 Oct; 28(5):485-487. PubMed ID: 30148769
[No Abstract] [Full Text] [Related]
39. Health-related quality of life impact in a randomised phase III study of the combination of dabrafenib and trametinib versus dabrafenib monotherapy in patients with BRAF V600 metastatic melanoma.
Schadendorf D; Amonkar MM; Stroyakovskiy D; Levchenko E; Gogas H; de Braud F; Grob JJ; Bondarenko I; Garbe C; Lebbe C; Larkin J; Chiarion-Sileni V; Millward M; Arance A; Mandalà M; Flaherty KT; Nathan P; Ribas A; Robert C; Casey M; DeMarini DJ; Irani JG; Aktan G; Long GV
Eur J Cancer; 2015 May; 51(7):833-40. PubMed ID: 25794603
[TBL] [Abstract][Full Text] [Related]
40. Cytohistologic correlation of basaloid salivary gland neoplasms: Can cytomorphologic classification be used to diagnose and grade these tumors?
Gargano SM; Sebastiano C; Solomides CC; Griffith CC; HooKim K
Cancer Cytopathol; 2020 Feb; 128(2):92-99. PubMed ID: 31742931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
